Located 35 miles north of San Diego, our Oceanside, CA campus is a biologics drug substance manufacturing facility with parallel commercial production and launch capabilities (from clinical to commercial) that deliver innovative new medicines to patients. The campus spans 60 acres, with seven buildings,~575,000 square feet, and 90,000 liters of capacity.
We are expanding our next-generation manufacturing network with a new commercial biologics facility in Oceanside, which will be the first of its kind in our global manufacturing network dedicated to full-scale commercial production. The facility is part of a ~$450 million investment in advanced manufacturing capabilities in Oceanside and is modeled after the Clinical Supply Center in South San Francisco, incorporating the same technologies and sustainability practices. By standardizing the design of the two facilities, we will significantly reduce the amount of time needed to transfer production from the clinical to commercial site. Once the new facility is operational in early 2025, it will just take a matter of days – instead of the traditional six to eighteen months – to complete this process, ultimately getting medicines to patients faster and more sustainably.